ArticleCancers2025

Real-World Outcomes of Ipilimumab-Nivolumab vs. Anti-PD-1 Monotherapy in Metastatic Uveal Melanoma: A Single-Center Retrospective Study.

Gitta Pánczél et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.